.png)
IVD Infectious Diseases Market by Product Type and Application- Global Industry Analysis & Forecast to 2027
Published On : December 2020 Pages : 158 Category: Pharma & Healthcare Report Code : HC1214376
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
IVD Infectious Diseases Market By Product Type (Instruments, Reagents, Software) and Application (MRSA, Streptococcus, Clostridium difficile, Vancomycin-resistant enterococci, Carbapenem-resistant bacteria testing, Respiratory virus, Candida, Tuberculosis and drug-resistant TB, Gastro-intestinal panel testing, Chlamydia, Gonorrhea, Others)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The IVD Infectious Diseases Markethas encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.IVD Infectious Diseasescan increase risk of hospital admission and death among people with pre‐existing chronic diseasesand it is common to approach chronic and infectious diseases as having completely distinct aetiologies, there is an increasing appreciation for the common determinants of health.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global IVD Infectious Diseases Market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Turkey
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Roche Diagnostics
- Abbott Laboratories
- Alere,
- Gen-Probe, Inc. (a part of Hologic, Inc.)
- Becton Dickinson (BD) Company, Inc.
- Bio-Rad Laboratories
- Siemens Healthcare,
- bioMeriux SA.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· IVD Infectious Diseases Market, By Product Type, Estimates and Forecast, 2017-2027 ($Million)
o Instruments
o Reagents
o Software
· IVD Infectious Diseases Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o MRSA,
o Streptococcus
o Clostridium difficile
o Vancomycin-resistant enterococci
o Carbapenem-resistant bacteria testing, Respiratory virus, Candida
o Tuberculosis and drug-resistant TB
o Gastro-intestinal panel testing
o Chlamydia
o Gonorrhea
o Others
· IVD Infectious Diseases Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Roche Diagnostics
o Abbott Laboratories
o Alere,
o Gen-Probe, Inc. (a part of Hologic, Inc.)
o Becton Dickinson (BD) Company, Inc.
o Bio-Rad Laboratories
o Siemens Healthcare,
· IVD Infectious Diseases Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America IVD Infectious Diseases Market, By Country
o U.S. IVD Infectious Diseases Market
o Canada IVD Infectious Diseases Market
o Mexico IVD Infectious Diseases Market
o Europe
§ Europe IVD Infectious Diseases Market, By Country
o UK IVD Infectious Diseases Market
o Germany IVD Infectious Diseases Market
o France IVD Infectious Diseases Market
o Russia IVD Infectious Diseases Market
o Italy IVD Infectious Diseases Market
o Rest of Europe IVD Infectious Diseases Market
o Asia-Pacific
§ Asia-Pacific IVD Infectious Diseases Market, By Country
o China IVD Infectious Diseases Market
o Japan IVD Infectious Diseases Market
o South Korea IVD Infectious Diseases Market
o India IVD Infectious Diseases Market
o Southeast Asia IVD Infectious Diseases Market
o Rest of Asia-Pacific IVD Infectious Diseases Market
o South America
§ South America IVD Infectious Diseases Market
o Brazil IVD Infectious Diseases Market
o Argentina IVD Infectious Diseases Market
o Columbia IVD Infectious Diseases Market
o Rest of South America IVD Infectious Diseases Market
o Middle East and Africa
§ Middle East and Africa IVD Infectious Diseases Market
o Saudi Arabia IVD Infectious Diseases Market
o UAE IVD Infectious Diseases Market
o Egypt IVD Infectious Diseases Market
o Nigeria IVD Infectious Diseases Market
o South Africa IVD Infectious Diseases Market
o TurkeyIVD Infectious Diseases Market
o Rest of MEA IVD Infectious Diseases Market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. IVD Infectious Diseases Market, By Product Type
5.1. Introduction
5.2. Global IVD Infectious Diseases Revenue and Market Share by Product Type (2017-2021)
5.2.1. Global IVD Infectious Diseases Revenue and Revenue Share by Product Type (2017-2021)
5.3. Instruments
5.3.1. Global Instruments Revenue and Growth Rate (2017-2021)
5.4. Reagents
5.4.1. Global Reagents Revenue and Growth Rate (2017-2021)
5.5. Software
5.5.1. Global Software Revenue and Growth Rate (2017-2021)
6. IVD Infectious Diseases Market, By Applications
6.1. Introduction
6.2. Global IVD Infectious Diseases Revenue and Market Share by Applications (2017-2021)
6.2.1. Global IVD Infectious Diseases Revenue and Revenue Share by Applications (2017-2021)
6.3. MRSA
6.3.1. Global MRSA Revenue and Growth Rate (2017-2021)
6.4. Streptococcus
6.4.1. Global Streptococcus Revenue and Growth Rate (2017-2021)
6.5. Clostridium difficile
6.5.1. Global Clostridium difficile Revenue and Growth Rate (2017-2021)
6.6. Vancomycin-resistant enterococci
6.6.1. Global Vancomycin-resistant enterococci Revenue and Growth Rate (2017-2021)
6.7. Carbapenem-resistant bacteria testing, Respiratory virus, Candida
6.7.1. Global Carbapenem-resistant bacteria testing, Respiratory virus, Candida Revenue and Growth Rate (2017-2021)
6.8. Tuberculosis and drug-resistant TB
6.8.1. Global Tuberculosis and drug-resistant TB Revenue and Growth Rate (2017-2021)
6.9. Gastro-intestinal panel testing
6.9.1. Global Gastro-intestinal panel testing Revenue and Growth Rate (2017-2021)
6.10. Chlamydia
6.10.1. Global Chlamydia Revenue and Growth Rate (2017-2021)
6.11. Gonorrhea
6.11.1. Global Gonorrhea Revenue and Growth Rate (2017-2021)
6.12. Others
6.12.1. Global Others Revenue and Growth Rate (2017-2021)
7. IVD Infectious Diseases Market, By Region
7.1. Introduction
7.2. Global IVD Infectious Diseases Revenue and Market Share by Regions
7.2.1. Global IVD Infectious Diseases Revenue by Regions (2017-2021)
7.3. North America IVD Infectious Diseases by Countries
7.3.1. North America IVD Infectious Diseases Revenue and Growth Rate (2017-2021)
7.3.2. North America IVD Infectious Diseases Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe IVD Infectious Diseases by Countries
7.4.1. Europe IVD Infectious Diseases Revenue and Growth Rate (2017-2021)
7.4.2. Europe IVD Infectious Diseases Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific IVD Infectious Diseases by Countries
7.5.1. Asia-Pacific IVD Infectious Diseases Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific IVD Infectious Diseases Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America IVD Infectious Diseases by Countries
7.6.1. South America IVD Infectious Diseases Revenue and Growth Rate (2017-2021)
7.6.2. South America IVD Infectious Diseases Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa IVD Infectious Diseases by Countries
7.7.1. Middle East and Africa IVD Infectious Diseases Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa IVD Infectious Diseases Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Roche Diagnostics
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Abbott Laboratories
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Alere
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Gen-Probe, Inc. (a part of Hologic, Inc.)
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Becton Dickinson (BD) Company, Inc.
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Bio-Rad Laboratories
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Siemens Healthcare,
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. bioMeriux SA.
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
9. IVD Infectious Diseases Market Forecast (2022-2027)
9.1. Global IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. IVD Infectious Diseases Market Forecast by Regions (2022-2027)
9.2.1. North America IVD Infectious Diseases Market Forecast (2022-2027)
9.2.1.1. United States IVD Infectious Diseases Market Forecast (2022-2027)
9.2.1.2. Canada IVD Infectious Diseases Market Forecast (2022-2027)
9.2.1.3. Mexico IVD Infectious Diseases Market Forecast (2022-2027)
9.2.2. Europe IVD Infectious Diseases Market Forecast (2022-2027)
9.2.2.1. Germany IVD Infectious Diseases Market Forecast (2022-2027)
9.2.2.2. France IVD Infectious Diseases Market Forecast (2022-2027)
9.2.2.3. UK IVD Infectious Diseases Market Forecast (2022-2027)
9.2.2.4. Russia IVD Infectious Diseases Market Forecast (2022-2027)
9.2.2.5. Italy IVD Infectious Diseases Market Forecast (2022-2027)
9.2.2.6. Rest of Europe IVD Infectious Diseases Market Forecast (2022-2027)
9.2.3. Asia-Pacific IVD Infectious Diseases Market Forecast (2022-2027)
9.2.3.1. China IVD Infectious Diseases Market Forecast (2022-2027)
9.2.3.2. Japan IVD Infectious Diseases Market Forecast (2022-2027)
9.2.3.3. Korea IVD Infectious Diseases Market Forecast (2022-2027)
9.2.3.4. India IVD Infectious Diseases Market Forecast (2022-2027)
9.2.3.5. Southeast Asia IVD Infectious Diseases Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific IVD Infectious Diseases Market Forecast (2022-2027)
9.2.4. South America IVD Infectious Diseases Market Forecast (2022-2027)
9.2.4.1. Brazil IVD Infectious Diseases Market Forecast (2022-2027)
9.2.4.2. Argentina IVD Infectious Diseases Market Forecast (2022-2027)
9.2.4.3. Columbia IVD Infectious Diseases Market Forecast (2022-2027)
9.2.4.4. Rest of South America IVD Infectious Diseases Market Forecast (2022-2027)
9.2.5. Middle East and Africa IVD Infectious Diseases Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia IVD Infectious Diseases Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates IVD Infectious Diseases Market Forecast (2022-2027)
9.2.5.3. Egypt IVD Infectious Diseases Market Forecast (2022-2027)
9.2.5.4. Nigeria IVD Infectious Diseases Market Forecast (2022-2027)
9.2.5.5. South Africa IVD Infectious Diseases Market Forecast (2022-2027)
9.2.5.6. Turkey IVD Infectious Diseases Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa IVD Infectious Diseases Market Forecast (2022-2027)
9.3. IVD Infectious Diseases Market Forecast by Product Type (2022-2027)
9.3.1. IVD Infectious Diseases Forecast by Product Type (2022-2027)
9.3.2. IVD Infectious Diseases Market Share Forecast by Product Type (2022-2027)
9.4. IVD Infectious Diseases Market Forecast by Applications (2022-2027)
9.4.1. IVD Infectious Diseases Forecast by Applications (2022-2027)
9.4.2. IVD Infectious Diseases Market Share Forecast by Applications (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States IVD Infectious Diseases Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada IVD Infectious Diseases Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico IVD Infectious Diseases Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany IVD Infectious Diseases Revenue (Million USD) and Growth Rate (2017-2027)
Figure France IVD Infectious Diseases Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK IVD Infectious Diseases Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia IVD Infectious Diseases Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy IVD Infectious Diseases Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe IVD Infectious Diseases Revenue (Million USD) and Growth Rate (2017-2027)
Figure China IVD Infectious Diseases Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan IVD Infectious Diseases Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea IVD Infectious Diseases Revenue (Million USD) and Growth Rate (2017-2027)
Figure India IVD Infectious Diseases Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia IVD Infectious Diseases Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific IVD Infectious Diseases Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil IVD Infectious Diseases Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina IVD Infectious Diseases Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia IVD Infectious Diseases Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America IVD Infectious Diseases Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia IVD Infectious Diseases Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates IVD Infectious Diseases Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt IVD Infectious Diseases Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria IVD Infectious Diseases Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa IVD Infectious Diseases Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey IVD Infectious Diseases Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa IVD Infectious Diseases Revenue (Million USD) and Growth Rate (2017-2027)
Table Global IVD Infectious Diseases Revenue and Revenue Share by Product Type (2017-2019)
Figure Global Instruments Revenue and Growth Rate (2017-2019)
Figure Global Reagents Revenue and Growth Rate (2017-2019)
Figure Global Software Revenue and Growth Rate (2017-2019)
Table Global IVD Infectious Diseases Revenue and Revenue Share by Applications (2017-2019)
Figure Global MRSA Revenue and Growth Rate (2017-2019)
Figure Global Streptococcus Revenue and Growth Rate (2017-2019)
Figure Global Clostridium difficile Revenue and Growth Rate (2017-2019)
Figure Global Vancomycin-resistant enterococci Revenue and Growth Rate (2017-2019)
Figure Global Carbapenem-resistant bacteria testing, Respiratory virus, Candida Revenue and Growth Rate (2017-2019)
Figure Global Tuberculosis and drug-resistant TB Revenue and Growth Rate (2017-2019)
Figure Global Gastro-intestinal panel testing Revenue and Growth Rate (2017-2019)
Figure Global Chlamydia Revenue and Growth Rate (2017-2019)
Figure Global Gonorrhea Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global IVD Infectious Diseases Revenue by Regions (2017-2019)
Figure North America IVD Infectious Diseases Growth Rate (2017-2019)
Figure North America IVD Infectious Diseases Revenue and Growth Rate (2017-2019)
Figure North America IVD Infectious Diseases by Countries (2017-2019)
Figure North America IVD Infectious Diseases Revenue (Million USD) by Countries (2017-2019)
Figure United States IVD Infectious Diseases Growth Rate (2017-2019)
Figure United States IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada IVD Infectious Diseases Growth Rate (2017-2019)
Figure Canada IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico IVD Infectious Diseases Growth Rate (2017-2019)
Figure Mexico IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe IVD Infectious Diseases Growth Rate (2017-2019)
Figure Europe IVD Infectious Diseases Revenue and Growth Rate (2017-2019)
Figure Europe IVD Infectious Diseases by Countries (2017-2019)
Figure Europe IVD Infectious Diseases Revenue (Million USD) by Countries (2017-2019)
Figure Germany IVD Infectious Diseases Growth Rate (2017-2019)
Figure Germany IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France IVD Infectious Diseases Growth Rate (2017-2019)
Figure France IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK IVD Infectious Diseases Growth Rate (2017-2019)
Figure UK IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia IVD Infectious Diseases Growth Rate (2017-2019)
Figure Russia IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy IVD Infectious Diseases Growth Rate (2017-2019)
Figure Italy IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe IVD Infectious Diseases Growth Rate (2017-2019)
Figure Rest of Europe IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific IVD Infectious Diseases Growth Rate (2017-2019)
Figure Asia-Pacific IVD Infectious Diseases Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific IVD Infectious Diseases by Countries (2017-2019)
Figure Asia-Pacific IVD Infectious Diseases Revenue (Million USD) by Countries (2017-2019)
Figure China IVD Infectious Diseases Growth Rate (2017-2019)
Figure China IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan IVD Infectious Diseases Growth Rate (2017-2019)
Figure Japan IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea IVD Infectious Diseases Growth Rate (2017-2019)
Figure Korea IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India IVD Infectious Diseases Growth Rate (2017-2019)
Figure India IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia IVD Infectious Diseases Growth Rate (2017-2019)
Figure Southeast Asia IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific IVD Infectious Diseases Growth Rate (2017-2019)
Figure Rest of Asia-Pacific IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America IVD Infectious Diseases Growth Rate (2017-2019)
Figure South America IVD Infectious Diseases Revenue and Growth Rate (2017-2019)
Figure South America IVD Infectious Diseases by Countries (2017-2019)
Figure South America IVD Infectious Diseases Revenue (Million USD) by Countries (2017-2019)
Figure Brazil IVD Infectious Diseases Growth Rate (2017-2019)
Figure Brazil IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina IVD Infectious Diseases Growth Rate (2017-2019)
Figure Argentina IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia IVD Infectious Diseases Growth Rate (2017-2019)
Figure Columbia IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America IVD Infectious Diseases Growth Rate (2017-2019)
Figure Rest of South America IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa IVD Infectious Diseases Growth Rate (2017-2019)
Figure Middle East and Africa IVD Infectious Diseases Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa IVD Infectious Diseases by Countries (2017-2019)
Figure Middle East and Africa IVD Infectious Diseases Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia IVD Infectious Diseases Growth Rate (2017-2019)
Figure Saudi Arabia IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates IVD Infectious Diseases Growth Rate (2017-2019)
Figure United Arab Emirates IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt IVD Infectious Diseases Growth Rate (2017-2019)
Figure Egypt IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria IVD Infectious Diseases Growth Rate (2017-2019)
Figure Nigeria IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa IVD Infectious Diseases Growth Rate (2017-2019)
Figure South Africa IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey IVD Infectious Diseases Growth Rate (2017-2019)
Figure Turkey IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa IVD Infectious Diseases Growth Rate (2017-2019)
Figure Rest of Middle East and Africa IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2017-2019)
Table Roche Diagnostics IVD Infectious Diseases Financial Overview
Table Abbott Laboratories IVD Infectious Diseases Financial Overview
Table Alere IVD Infectious Diseases Financial Overview
Table Gen-Probe, Inc. (a part of Hologic, Inc.) IVD Infectious Diseases Financial Overview
Table Becton Dickinson (BD) Company, Inc. IVD Infectious Diseases Financial Overview
Table Bio-Rad Laboratories IVD Infectious Diseases Financial Overview
Table Siemens Healthcare, IVD Infectious Diseases Financial Overview
Table bioMeriux SA. IVD Infectious Diseases Financial Overview
Figure Global IVD Infectious Diseases Revenue (Millions USD) and Growth Rate (2019-2027)
Table IVD Infectious Diseases Market Forecast by Regions (2019-2027)
Figure North America IVD Infectious Diseases Market Forecast (2019-2027)
Figure United States IVD Infectious Diseases Market Forecast (2019-2027)
Figure Canada IVD Infectious Diseases Market Forecast (2019-2027)
Figure Mexico IVD Infectious Diseases Market Forecast (2019-2027)
Figure Europe IVD Infectious Diseases Market Forecast (2019-2027)
Figure Germany IVD Infectious Diseases Market Forecast (2019-2027)
Figure France IVD Infectious Diseases Market Forecast (2019-2027)
Figure UK IVD Infectious Diseases Market Forecast (2019-2027)
Figure Russia IVD Infectious Diseases Market Forecast (2019-2027)
Figure Italy IVD Infectious Diseases Market Forecast (2019-2027)
Figure Rest of Europe IVD Infectious Diseases Market Forecast (2019-2027)
Figure Asia-Pacific IVD Infectious Diseases Market Forecast (2019-2027)
Figure China IVD Infectious Diseases Market Forecast (2019-2027)
Figure Japan IVD Infectious Diseases Market Forecast (2019-2027)
Figure Korea IVD Infectious Diseases Market Forecast (2019-2027)
Figure India IVD Infectious Diseases Market Forecast (2019-2027)
Figure Southeast Asia IVD Infectious Diseases Market Forecast (2019-2027)
Figure Rest of Asia-Pacific IVD Infectious Diseases Market Forecast (2019-2027)
Figure South America IVD Infectious Diseases Market Forecast (2019-2027)
Figure Brazil IVD Infectious Diseases Market Forecast (2019-2027)
Figure Argentina IVD Infectious Diseases Market Forecast (2019-2027)
Figure Columbia IVD Infectious Diseases Market Forecast (2019-2027)
Figure Rest of South America IVD Infectious Diseases Market Forecast (2019-2027)
Figure Middle East and Africa IVD Infectious Diseases Market Forecast (2019-2027)
Figure Saudi Arabia IVD Infectious Diseases Market Forecast (2019-2027)
Figure United Arab Emirates IVD Infectious Diseases Market Forecast (2019-2027)
Figure Egypt IVD Infectious Diseases Market Forecast (2019-2027)
Figure Nigeria IVD Infectious Diseases Market Forecast (2019-2027)
Figure South Africa IVD Infectious Diseases Market Forecast (2019-2027)
Figure Turkey IVD Infectious Diseases Market Forecast (2019-2027)
Figure Rest of Middle East and Africa IVD Infectious Diseases Market Forecast (2019-2027)
Figure Global IVD Infectious Diseases Forecast by Product Type (2019-2027)
Figure Global IVD Infectious Diseases Market Share Forecast by Product Type (2019-2027)
Figure Global IVD Infectious Diseases Forecast by Product Type (2019-2027)
Figure Global IVD Infectious Diseases Forecast by Applications (2019-2027)
Figure Global IVD Infectious Diseases Market Share Forecast by Applications (2019-2027)
Figure Global IVD Infectious Diseases Forecast by Applications (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|